“…Starch branching enzyme II ( sbeII ) wheat mutants obtained by Targeting Induced Local Lesions in Genomes (TILLING), a non-transgenic technology (McCallum, Comai, Greene, & Henikoff, 2000), can produce starch with higher amylose content than conventional wheat starch (Schonhofen A., Zhang X., & Dubcovsky J., 2017). Foods made from sbeII wheat flour have lower starch digestibility and could therefore be used to lower glycaemic responses to starch-rich staple foods (Corrado M., et al, 2022; Corrado M., et al, 2020; Sissons M., Sestili F., Botticella E., Masci S., & Lafiandra D., 2020).…”